(Q36502928)

14 August 2017

title

Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature (English)

1 reference

14 August 2017

1 reference

1 reference

Mehran Taban

1

1 reference

14 August 2017

William J Dupps

series ordinal

2

1 reference

14 August 2017

Brian Mandell

series ordinal

3

1 reference

14 August 2017

Victor L Perez

series ordinal

4

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Ocular Immunology and Inflammation

14 August 2017

published in

1 reference

14 August 2017

volume

14

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

145-150

1 reference

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Long-term risks associated with biologic response modifiers used in rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Does etanercept induce uveitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Etanercept therapy in children with treatment-resistant uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

The German etanercept registry for treatment of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Approaches for identifying and defining environmentally associated rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940600659393

10.1080/09273940600659393

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference